2021 Western A-Fib Symposium Faculty Roster

Coming Soon

For your reference, all faculty and planners are listed below with their contact information, as it is received and authorized for release. Each of these specialists were asked to sign a disclosure noting any potential conflicts of interest related to financial relationships with a commercial interest(s) – defined as any entity producing, marketing, re-selling. or distributing healthcare goods or services consumed by, or used on patients. All disclosures received are noted below with each faculty member and planner.
(An asterisk denotes program planners)

All relevant financial relationships of faculty and planners were resolved prior to the symposium.


  • To share the latest and currently developing knowledge of the critical issues around atrial fibrillation and related systems involvement including, but not limited to stroke prevention, GI and gastroenterology involvement, and post-ablation bleeding.
  • To facilitate a focus on new, global technologies, recent research findings, and new procedures available for improved patient care.
  • To support the development and use of cost-effective procedures and treatments including but not limited to anti-fibrotic drugs, new EP techniques, and other pharmacologic agents.
  • To stimulate consensus building on treatment choices for recurrent arrhythmias pre and post -ablation, mobile health applications, ablation techniques, mapping and other current and developing technologies and interventions.
  • To provide a forum for global information sharing and integration of all concepts in the fields working on atrial fibrillation.